Insider trade

CFO exercised or converted 2,797 GILD derivative securities

Traded Sep 10, 2026 · Filed Sep 11, 2026

Gilead SciencesGILD

2,797
Shares

Why it stands out

Derivative exercise or conversion — not an open-market buy.

Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell

View the official recordSEC Form 4 — Statement of Changes in Beneficial Ownership

All the details

Dates, kept separate

Transaction date: Sep 10, 2026
Reporting period: Not applicable
Filed with the SEC: Sep 11, 2026

CFOOption exercise

Context

Classification

option exercise

Code M — exercise or conversion of a derivative security

Planned / mechanical clue

Footnote references vesting of compensation awards

Only flagged when a footnote says so; never inferred

Source receipt

Record ID: 0001310204-26-000027

Filed / recorded

Sep 11, 2026, 10:30 PM UTC

Added to OQRO

Oct 2, 2026, 12:27 PM UTC

Parser

form4-xml-v1

Data quality

Verified: identifiers matched exactly

Issuer

GILEAD SCIENCES, INC.

Issuer CIK

882095

Ticker

GILD

Reporting person

Andrew D Dickinson

Relationship

Officer

Officer title

Chief Financial Officer

Security

Common Stock

Table

Non-derivative (Table I)

Transaction date

Sep 10, 2026

Transaction code

M

Shares / units

2,797

Acquired / disposed

Acquired (A)

Shares owned after

168,443

Ownership form

Direct

Amendment

No

Footnotes from the filing

Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.

Around the same time

CEO sold ~$1.77M of Gilead Sciences

Scheduled in advance3d ago

CEO sold ~$446K of Gilead Sciences

Scheduled in advance3d ago

13d ago

2,223Shares

Derivative exercise or conversion — not an open-market buy.

Why it stands out Official record